Press release
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market
Angina Market Size
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a greater incidence of coronary heart disease, an escalated usage of vasodilators, a higher occurrence of myocardial ischemia, enhanced diagnostic aptitude, and a rise in the employment of imaging techniques.
Expectations are that the angina market size will exhibit robust growth in the forthcoming years. The market is projected to expand to $14.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. The growth over the forecast period could be due to multiple factors such as an increased incidence of chronic angina pectoris, a rise in approved drugs and clinical research, escalating needs for retail pharmacies, and an enhanced understanding of cardiovascular health, along with a growing requirement for medications. Key trends in the forecast period encompass progress in early diagnostic technologies, improvements in angioplasty and stenting procedures, innovative gene therapy methods, growing demand for coronary stents, and the progression in the treatment of coronary artery disease.
What Are the Key Drivers Behind the Growth of the Angina Market?
The surge in instances of coronary artery disease (CAD) is projected to stimulate the angina market's expansion. CAD, alternatively known as coronary heart disease (CHD) or ischemic heart disease (IHD), refers to a condition marked by the narrowing or obstruction of the coronary arteries responsible for supplying blood, oxygen, and nutrients to the heart muscle. This rise in CAD cases is attributed to alterations in lifestyle, environmental, and genetic influences. Angina serves an instrumental role in recognizing and interpreting the prevalence of coronary artery disease, prompting medical evaluations and diagnoses, assisting in risk stratification, directing treatment choices, and shaping public health approaches. For example, the American Heart Association stated in January 2023 that the number of adults in the U.S living with CAD increased from 18.2 million to approximately 19.3 million from 2021 to 2022. Consequently, the escalating cases of coronary artery diseases are driving the angina market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp
Which Businesses Are at the Forefront of Angina Market Development?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
What Are the Latest Innovations in the Angina Market?
Leading companies in the angina market are focusing on the development of innovative pharmaceuticals like metoprolol tartrate tablets to offer better and more precise treatment options for individuals suffering from coronary artery disease (CAD) and related ailments. Most commonly, metoprolol tartrate tablets are used to offer relief from cardiovascular conditions, such as angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, the US-FDA granted Zydus, a pharmaceutical company based in India, the final go-ahead to produce and sell its own version of Metoprolol Tartrate Tablets USP having strengths of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized to treat a variety of cardiovascular issues, including hypertension and angina, and also to enhance survival rates post a heart attack.
How Is the Angina Market Segmented?
The angina market covered in this report is segmented -
1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/angina-global-market-report
Where Is the Angina Market Growth Most Prominent?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Angina Global Market Report?
- Market Size Analysis: Analyze the Angina Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Angina Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Angina Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Angina Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market here
News-ID: 3855832 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Angina
Angina Market Key Players, Trends & Forecast to 2034
The Angina Market is experiencing steady growth worldwide as heart disease cases rise and healthcare providers adopt advanced diagnostic tools, novel anti-anginal medications, and cutting-edge interventional cardiology treatments. With precision diagnostics, long-acting drug therapies, and improved cardiac revascularization techniques, the market is set for substantial expansion through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52004
1. What Is Angina? (Keyword Definition)
Angina pectoris-commonly known as angina-is chest pain or discomfort caused…
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
Refractory Angina Market Highlights On Future Development 2025
Global Refractory Angina Market: Snapshot
In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows…
